Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Advocacy Leads to Legislator Access

Paula Marchetta, MD, MBA  |  Issue: June 2019  |  June 17, 2019

  1. The deleterious imposition of step therapy protocols;
  2. The burdensome and unnecessary requirements for obtaining prior authorizations and pre-approvals for indicated treatments;
  3. The rheumatology workforce shortage and its growing impact on access to care for our patients;
  4. The need to address the meager reimbursement for dual-energy X-ray absorptiometry (DXA), which diminishes access to osteoporosis screening, because so many testing sites have been forced to close; and
  5. The urgent need for more research funding, especially through the U.S. Department of Defense, because arthritis is the leading cause of disability and discharge among servicemen and women.

Come this September, the ACR will offer our general membership and patients the opportunity to go to Capitol Hill with our volunteer leaders as part of the ACR’s Advocates for Arthritis Fly-In. The appli­cations to join us Sept. 8–10 are now available.

For those who prefer to meet federal legislators on our home turf or would like to continue to build relationships with senators and House representatives after the D.C. meetings, the ACR can facilitate access to federal lawmakers locally, either through district meetings or at fundraising events through RheumPAC (see below). It is also possible to invite a legislator to visit your practice. This is one of the best ways for officials to get a feel for the care we, as rheumatologists and members of the interprofessional team, provide our patients. They can see firsthand the impact we have on our patients’ quality of life, as well as the challenges our patients and we, as their providers, face every day.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

The ACR also provides our members with a vehicle for year-round direct access to Congress through the Legislative Action Center. Here, we can directly write to our lawmakers. Precomposed, editable messages on a range of issues facing rheumatology practices and patients are available for us to consider sending. In addition, the ACR’s professional advocacy staff communicates year-round directly with Hill offices and staff on the priority issues of the rheumatology community. We can influence legislation and advance key bills due to these ongoing contacts and relationships.

Access to Decision Makers & Rheumatology Champions

RheumPAC—One of the most effective ways the rheumatology community can make a difference and increase access is through the ACR’s Political Action Committee for Rheumatology: RheumPAC. Donations to RheumPAC (or perhaps better said, investments in RheumPAC) from ACR and ARP members allow us to give financial support to the campaigns of rheumatology champions in Congress. These legislators feel they have the backing of the membership through RheumPAC, and this, in turn, gives additional access to these members of Congress through fundraising events or by their coming to present to us at ACR Advocacy meetings.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

RheumPAC contributions, made possible through our investments in RheumPAC, help preserve the seats of our champions in Congress. These champions fight for us on issues important to rheumatology; they let us know when bills relevant to rheumatology are coming up, and they introduce new bills to address our issues. Learn more at RheumPAC.

The ACR also participates in advocacy events with other medical specialties. These meetings allow targeted conversations on topics of interest we share with other cognitive specialties, such as workforce shortages and the onus of prior authorizations. These informal settings allow for updates on politics and caucus discussions surrounding greater healthcare themes, including the various Medicare-for-All bills or rural legislators’ conversations about access to care in their states.

Page: 1 2 3 4 | Single Page
Share: 

Filed under:Legislation & AdvocacyPresident's Perspective Tagged with:Centers for Medicare & Medicaid Services (CMS)E/M codesRheumPAC

Related Articles

    A Huge Thank You to 251 People

    March 18, 2011

    RheumPAC supporters are helping to advance rheumatology

    Advancing the ACR’s Legislative Priorities in 2021

    January 11, 2021

    With a new Congress and many new legislators in key leadership positions, your support today will help RheumPAC start the year off strong.

    I RheumPAC, Do You?

    September 1, 2009

    For many years, the ACR board of directors and Government Affairs Committee have done exemplary work in keeping members abreast of legislative regulatory issues that affect all aspects of rheumatology, including patient and physician/healthcare professional issues, education, and research. Through advocacy, the ACR advances rheumatology and fosters excellence in the care of people with, or at risk for, arthritis and rheumatic and musculoskeletal diseases. One might say that advocacy is a cornerstone of this organization.

    PAC Progress and Challenges

    November 1, 2009

    After three years, RheumPAC has a solid start, and more work ahead of it

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences